Modifying the uses, disclosure, and requirement dates of prescription drug price transparency data.
Bill status
passed
3 of 5 stages cleared
Introduction
Jan 2020
Committee Review
Feb 2020
House Passage
Feb 2020
Senate Passage
Governor
Introduced Jan 20, 2020
Last action Mar 12, 2020
Floor votes · House Feb 17, 2020
How they voted
54–40
Passed
Total votes 94
Feb 17, 2020
D
Democratic55
98% Yea
R
Republican39
100% Nay
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
12
Key actions
5
Committee
5
Feb 28, 2020
Upper · Passed
Scheduled for public hearing in the Senate Committee on Health & Long Term Care at 08:00 AM
upper
Feb 17, 2020
House · Passed
House Vote: pass (54-40)
house
Feb 6, 2020
Committee
Referred to Rules 2 Review.
lower
Feb 4, 2020
Lower · Passed
Scheduled for public hearing in the House Committee on Health Care & Wellness at 01:30 PM
lower
Feb 4, 2020
Lower · Passed
HCW - Majority; do pass.
lower
Jan 29, 2020
Lower · Passed
Scheduled for public hearing in the House Committee on Health Care & Wellness at 01:30 PM
lower
1 primary · 4 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 2710
Scope: WA
Hi! I can help you understand HB 2710. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline